glp 1 and 2 Dual GIP/GLP-1 receptor agonists: New advances for treating type-2 diabetes GLP-1-based therapies for type 2

Development of a Skin Patch Capable of Detecting Skin Cancers through Protein Capture, Protection, and Analysis, Shiv Saini, Alexander Nixon, Kelsey Mitchell, Alessandra Luchini, Lance Liotta, Ruben Magni 16

GHK-Cu reduces inflammatory markers including TNF-alpha and IL-6

Metascape provides a biologist-oriented resource for the analysis of systems-level datasets

Keeping a simple injection diary or using a smartphone app can help patients track their rotation pattern, particularly important for those using multiple injectable medications

Store at room temperature only

Victoza: A daily injection approved for adults and pediatric patients (10+) with type 2 diabetes